Marshall Wace North America L.P. acquired a new position in shares of Colgate-Palmolive (NYSE:CL) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 19,928 shares of the company’s stock, valued at approximately $1,372,000.
Several other institutional investors also recently made changes to their positions in CL. Ilmarinen Mutual Pension Insurance Co bought a new stake in Colgate-Palmolive during the 3rd quarter worth approximately $6,270,000. Merit Financial Group LLC grew its position in Colgate-Palmolive by 2.7% during the 3rd quarter. Merit Financial Group LLC now owns 6,545 shares of the company’s stock worth $481,000 after acquiring an additional 171 shares during the last quarter. Stifel Financial Corp grew its position in Colgate-Palmolive by 5.4% during the 3rd quarter. Stifel Financial Corp now owns 287,766 shares of the company’s stock worth $21,149,000 after acquiring an additional 14,850 shares during the last quarter. Global Retirement Partners LLC boosted its position in Colgate-Palmolive by 16.1% in the 3rd quarter. Global Retirement Partners LLC now owns 2,685 shares of the company’s stock valued at $197,000 after buying an additional 373 shares during the last quarter. Finally, Andra AP fonden boosted its position in Colgate-Palmolive by 1.9% in the 3rd quarter. Andra AP fonden now owns 89,700 shares of the company’s stock valued at $6,594,000 after buying an additional 1,700 shares during the last quarter. 77.84% of the stock is owned by institutional investors and hedge funds.
In other Colgate-Palmolive news, Chairman Ian M. Cook sold 17,750 shares of Colgate-Palmolive stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $69.11, for a total value of $1,226,702.50. Following the sale, the chairman now owns 1,042,241 shares of the company’s stock, valued at approximately $72,029,275.51. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Philip G. Shotts sold 666 shares of Colgate-Palmolive stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $75.61, for a total value of $50,356.26. Following the completion of the sale, the vice president now directly owns 41,158 shares in the company, valued at approximately $3,111,956.38. The disclosure for this sale can be found here. Insiders have sold a total of 261,607 shares of company stock worth $19,590,445 in the last ninety days. 1.14% of the stock is currently owned by company insiders.
A number of research firms have recently weighed in on CL. Berenberg Bank reissued a “sell” rating and issued a $58.00 price target on shares of Colgate-Palmolive in a research note on Tuesday, February 4th. Atlantic Securities raised Colgate-Palmolive from a “neutral” rating to an “overweight” rating in a research note on Monday, February 3rd. Morgan Stanley raised Colgate-Palmolive from an “equal weight” rating to an “overweight” rating and cut their price target for the company from $76.00 to $72.00 in a research note on Sunday. SunTrust Banks reissued a “hold” rating and issued a $70.00 price target on shares of Colgate-Palmolive in a research note on Monday, February 3rd. Finally, Royal Bank of Canada raised Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and increased their price target for the company from $69.00 to $91.00 in a research note on Monday, February 3rd. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and eight have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $74.73.
Shares of Colgate-Palmolive stock opened at $59.89 on Thursday. The company has a market capitalization of $52.31 billion, a PE ratio of 21.78, a PEG ratio of 3.61 and a beta of 0.73. Colgate-Palmolive has a 12 month low of $58.49 and a 12 month high of $77.41. The company has a current ratio of 1.03, a quick ratio of 0.69 and a debt-to-equity ratio of 13.14. The stock’s fifty day simple moving average is $71.68 and its 200 day simple moving average is $69.94.
Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, January 31st. The company reported $0.73 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.73. The business had revenue of $4.02 billion for the quarter, compared to the consensus estimate of $3.93 billion. Colgate-Palmolive had a return on equity of 1,906.25% and a net margin of 15.08%. The firm’s revenue was up 5.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.74 EPS. Analysts predict that Colgate-Palmolive will post 2.96 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Monday, April 20th will be paid a dividend of $0.44 per share. This represents a $1.76 annualized dividend and a yield of 2.94%. The ex-dividend date of this dividend is Friday, April 17th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.43. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 60.78%.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
Further Reading: What does a market perform rating mean?
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.